Baxion
Screening
Tags
Alerts
Theme
Psyence Biomedical Ltd.
PBM
·
NASDAQ
·
$4.49
Share Price as of 11/2
·
$85,395
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
06/22/26
20-F/A
Annual report (foreign, amended)
07/25/25
20-F
Annual report (foreign)
06/25/25
20-F
Annual report (foreign)
07/29/24
20-F
Annual report (foreign)
01/31/24
Disclosures
Filter
6-K
Foreign issuer report
10/21/26
6-K
Foreign issuer report
10/05/26
6-K
Foreign issuer report
09/28/26
6-K
Foreign issuer report
09/23/26
6-K
Foreign issuer report
09/14/26
Prospectuses and Registrations
Filter
F-3
Shelf registration (foreign)
08/26/26
S-8
Registration of securities for employees
08/26/26
424B3
Prospectus
11/20/25
424B3
Prospectus
11/12/25
424B3
Prospectus
11/03/25
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/15/26
SC 13G
Beneficial ownership
10/05/26
SC 13G/A
Beneficial ownership (amended)
06/10/26
SC 13D
Beneficial ownership
06/03/26
SC 13G
Beneficial ownership
02/19/26
Other
Filter
EFFECT
Request for effectiveness
09/01/26
CORRESP
Correspondence with the SEC
10/06/25
UPLOAD
Letter from the SEC
08/13/25
EFFECT
Request for effectiveness
03/14/25
CORRESP
Correspondence with the SEC
03/13/25
Latest Filings
Filter
6-K
Foreign issuer report
10/21/26
6-K
Foreign issuer report
10/05/26
6-K
Foreign issuer report
09/28/26
6-K
Foreign issuer report
09/23/26
6-K
Foreign issuer report
09/14/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/15/26
SC 13G
Beneficial ownership
10/05/26
SC 13G/A
Beneficial ownership (amended)
06/10/26
SC 13D
Beneficial ownership
06/03/26
SC 13G
Beneficial ownership
02/19/26